BioRestorative Therapies, Inc. (BRTX)

0.1982 0.00 (0.00%) USD  |  NASDAQ  |  Sep 01, 16:00
0.20 0.00 (0.00%) Pre-Market: 09:24
More

BioRestorative Therapies Revenue Estimates for Next Fiscal Year

Revenue Estimates for Next Fiscal Year Chart

View Revenue Estimates for Next Fiscal Year for BRTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Estimates for Next Fiscal Year Chart
Start Trial

Historical Revenue Estimates for Next Fiscal Year Data

View and export this data back to 2023. Start Trial.
Date Value
April 08, 2026 --
April 02, 2026 --
February 17, 2026 --
February 12, 2026 --
November 14, 2025 --
November 12, 2025 --
August 13, 2025 --
August 12, 2025 --
June 13, 2025 --
May 21, 2025 --
May 14, 2025 --
March 28, 2025 --
February 28, 2025 --
February 27, 2025 --
February 11, 2025 --
February 10, 2025 --
November 15, 2024 --
November 14, 2024 --
Date Value
August 14, 2024 --
June 27, 2024 --
June 13, 2024 --
June 12, 2024 --
May 17, 2024 --
April 16, 2024 --
April 08, 2024 --
April 01, 2024 --
February 12, 2024 --
February 05, 2024 --
December 29, 2023 --
June 27, 2023 --
May 08, 2023 --
April 24, 2023 --
March 31, 2023 --
March 15, 2023 --
March 02, 2023 --
February 08, 2023 --

Revenue Estimates for Next Fiscal Year Range, Past 5 Years

View Revenue Estimates for Next Fiscal Year Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Next Fiscal Year Benchmarks

View Revenue Estimates for Next Fiscal Year Benchmarks
Start Trial
Myriad Genetics, Inc. Upgrade
CareDx, Inc. Upgrade
Natera, Inc. Upgrade
Exagen, Inc. Upgrade
Sera Prognostics, Inc. Upgrade

Revenue Estimates for Next Fiscal Year Related Metrics

Revenue Estimates for Current Quarter Upgrade
Revenue Estimates for Next Quarter Upgrade
Revenue Estimates for Current Fiscal Year Upgrade
EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade